Treatment Modalities for Non-small Cell Lung Cancer—A Clinical Survey
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (14 September 2023) | Viewed by 17384
Special Issue Editor
Interests: oncological thoracic surgery; photodynamic therapy (PDT); oncological immunology; tumor microenvironment; biomarkers and prognostic parameters; palliative tumor therapy
Special Issue Information
Dear Colleagues,
Lung cancer is one of the most aggressive types of cancer, with non-small-cell lung cancer being the most common histologic subtype of primary lung cancer. Despite continuous progress in surgery, chemotherapy, radiation therapy, and immune and targeted therapies, the prognosis of non-small-cell lung cancer patients still remains modest, especially those with advanced tumor disease. For this reason, this Special Issue of Cancers will highlight the different surgical and non-surgical treatment modalities available for non-small-cell lung cancer, focusing on the clinical aspect and related research activity. In this context, special attention will be paid to the current multimodal treatment options, to the impact of oncological immunology, and to the role of the tumor microenvironment in order to provide a comprehensive overview of this challenging topic.
Dr. Joerg Lindenmann
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- minimally-invasive thoracic surgery
- extended resections
- photodynamic therapy
- immune therapy
- targeted therapy
- radiation therapy
- multimodality treatment
- tumor microenvironment
- prognostic markers